# Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating Acute Ischemic Stroke

> **NCT06518902** · PHASE1 · NOT_YET_RECRUITING · sponsor: **National Engineering Center of Cell Products** · enrollment: 18 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** mesenchymal stem cells (umbilical cord) injection

## Key facts

- **NCT ID:** NCT06518902
- **Lead sponsor:** National Engineering Center of Cell Products
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08
- **Primary completion:** 2025-07
- **Final completion:** 2025-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06518902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06518902, "Umbilical Cord-derived Mesenchymal Stem Cell Infusion for Treating Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06518902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*